TARLATAMAB-DLLE for Small cell lung cancer extensive stage: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 127 adverse event reports in the FDA FAERS database where TARLATAMAB-DLLE was used for Small cell lung cancer extensive stage.

Most Reported Side Effects for TARLATAMAB-DLLE

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	274	34.1%	36	103
Immune effector cell-associated neurotoxicity syndrome	127	15.8%	15	51
Off label use	111	13.8%	5	36
Pyrexia	75	9.3%	4	26
Small cell lung cancer	66	8.2%	22	19
Death	45	5.6%	45	13
Disease progression	34	4.2%	9	5
Metastases to central nervous system	28	3.5%	0	6
Decreased appetite	23	2.9%	1	8
Dysgeusia	22	2.7%	1	2
Fatigue	22	2.7%	1	5
Headache	20	2.5%	1	6
Ageusia	17	2.1%	0	1
Hypotension	17	2.1%	1	6
Taste disorder	17	2.1%	1	2